Literature DB >> 15341687

Hypertension and dementia: does blood pressure control favorably affect cognition?

Elizabeth I Majeski1, Colin E Widener, Jan Basile.   

Abstract

Dementia and aging are not synonymous. Dementia is a progressive deterioration in cognitive and social and/or occupational functions that can eventually impair a patient's ability to live independently. Alzheimer's disease is the most common form of dementia. It accounts for 50% to 70% of all patients with dementia. Vascular dementia, responsible for up to 15% of all diagnosed cases, is the second most common form of dementia. Hypertension remains a significant risk factor for vascular dementia. The optimal level of blood pressure control for the prevention of dementia and whether one particular class of antihypertensive drug is more beneficial than another remains uncertain.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15341687     DOI: 10.1007/s11906-004-0054-0

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  28 in total

1.  Frontal systems impairment following multiple lacunar infarcts.

Authors:  N Wolfe; R Linn; V L Babikian; J E Knoefel; M L Albert
Journal:  Arch Neurol       Date:  1990-02

2.  Dementia and disability outcomes in large hypertension trials: lessons learned from the systolic hypertension in the elderly program (SHEP) trial.

Authors:  M Di Bari; M Pahor; L V Franse; R I Shorr; J Y Wan; L Ferrucci; G W Somes; W B Applegate
Journal:  Am J Epidemiol       Date:  2001-01-01       Impact factor: 4.897

3.  Multi-infarct dementia. A cause of mental deterioration in the elderly.

Authors:  V C Hachinski; N A Lassen; J Marshall
Journal:  Lancet       Date:  1974-07-27       Impact factor: 79.321

4.  The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study.

Authors:  Françoise Forette; Marie-Laure Seux; Jan A Staessen; Lutgarde Thijs; Marija-Ruta Babarskiene; Speranta Babeanu; Alfredo Bossini; Robert Fagard; Blas Gil-Extremera; Tovio Laks; Zhanna Kobalava; Cinzia Sarti; Jaakko Tuomilehto; Hannu Vanhanen; John Webster; Yair Yodfat; Willem H Birkenhäger
Journal:  Arch Intern Med       Date:  2002-10-14

5.  Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group.

Authors: 
Journal:  JAMA       Date:  1991-06-26       Impact factor: 56.272

6.  Statins and the risk of dementia.

Authors:  H Jick; G L Zornberg; S S Jick; S Seshadri; D A Drachman
Journal:  Lancet       Date:  2000-11-11       Impact factor: 79.321

7.  The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial.

Authors:  Hans Lithell; Lennart Hansson; Ingmar Skoog; Dag Elmfeldt; Albert Hofman; Bertil Olofsson; Peter Trenkwalder; Alberto Zanchetti
Journal:  J Hypertens       Date:  2003-05       Impact factor: 4.844

8.  A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study.

Authors:  M Sano; C Ernesto; R G Thomas; M R Klauber; K Schafer; M Grundman; P Woodbury; J Growdon; C W Cotman; E Pfeiffer; L S Schneider; L J Thal
Journal:  N Engl J Med       Date:  1997-04-24       Impact factor: 91.245

9.  Dietary intake of antioxidants and risk of Alzheimer disease.

Authors:  Marianne J Engelhart; Mirjam I Geerlings; Annemieke Ruitenberg; John C van Swieten; Albert Hofman; Jacqueline C M Witteman; Monique M B Breteler
Journal:  JAMA       Date:  2002-06-26       Impact factor: 56.272

10.  Alzheimer disease in the US population: prevalence estimates using the 2000 census.

Authors:  Liesi E Hebert; Paul A Scherr; Julia L Bienias; David A Bennett; Denis A Evans
Journal:  Arch Neurol       Date:  2003-08
View more
  2 in total

1.  C-reactive protein, but not homocysteine, is related to cognitive dysfunction in older adults with cardiovascular disease.

Authors:  John Gunstad; Linda Bausserman; Robert H Paul; David F Tate; Karin Hoth; Athena Poppas; Angela L Jefferson; Ronald A Cohen
Journal:  J Clin Neurosci       Date:  2006-05-24       Impact factor: 1.961

2.  Stimulus processing and associative learning in Wistar and WKHA rats.

Authors:  Amy C Chess; Christopher S Keene; Elizabeth C Wyzik; David J Bucci
Journal:  Behav Neurosci       Date:  2005-06       Impact factor: 1.912

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.